IBDEI204 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33957,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,33957,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,33958,0)
 ;;=D47.9^^131^1680^172
 ;;^UTILITY(U,$J,358.3,33958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33958,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,33958,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,33958,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,33959,0)
 ;;=D53.9^^131^1680^176
 ;;^UTILITY(U,$J,358.3,33959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33959,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,33959,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,33959,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,33960,0)
 ;;=D47.4^^131^1680^177
 ;;^UTILITY(U,$J,358.3,33960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33960,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,33960,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,33960,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,33961,0)
 ;;=D59.1^^131^1680^28
 ;;^UTILITY(U,$J,358.3,33961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33961,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,33961,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,33961,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,33962,0)
 ;;=D51.3^^131^1680^191
 ;;^UTILITY(U,$J,358.3,33962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33962,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,33962,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,33962,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,33963,0)
 ;;=D77.^^131^1680^57
 ;;^UTILITY(U,$J,358.3,33963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33963,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,33963,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,33963,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,33964,0)
 ;;=D58.2^^131^1680^83
 ;;^UTILITY(U,$J,358.3,33964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33964,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,33964,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,33964,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,33965,0)
 ;;=C88.8^^131^1680^103
 ;;^UTILITY(U,$J,358.3,33965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33965,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,33965,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,33965,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,33966,0)
 ;;=D70.8^^131^1680^174
 ;;^UTILITY(U,$J,358.3,33966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33966,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,33966,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,33966,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,33967,0)
 ;;=D59.4^^131^1680^175
 ;;^UTILITY(U,$J,358.3,33967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33967,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,33967,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,33967,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,33968,0)
 ;;=D69.59^^131^1680^181
 ;;^UTILITY(U,$J,358.3,33968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33968,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,33968,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,33968,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,33969,0)
 ;;=C22.7^^131^1680^46
 ;;^UTILITY(U,$J,358.3,33969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33969,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,33969,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,33969,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,33970,0)
 ;;=D75.89^^131^1680^56
 ;;^UTILITY(U,$J,358.3,33970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33970,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
